Roche receives FDA Emergency Use Authorization for the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 Systems

Basel, 04 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the cobas ® SARS-CoV-2&Influenza A/B Test for use on the cobas ® 6800/8800 Systems has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). This test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A and Influenza B in patients suspected by their healthcare provider of having respiratory viral infection consistent with COVID-19. Additionally, it is available in markets accepting the CE mark.“With the approaching flu season, this new test is particularly important as SARS-CoV-2 and influenza infections can hardly be differentiated by symptoms alone. Now, with a single test, healthcare professionals can confidently provide the right diagnosis and most effective treatment plan for their patients,” said Thomas Schinecker, CEO of Roche Diagnostics. “As a leader in diagnostics testing solutions, this launch demonstrates our ongoing commitment to stop the spread of serious infectious diseases by increasing access to accurate, reliable and efficient testing options.” Roche ’s widely-available, fully-automated cobas 6800/8800 Systems, which are used to perform the SARS-CoV-2&Influenza A/B Test, offer the fastest time to results with the highest throughput and the longest walk-away time available among automated molecular platforms. The systems provide up to 96 results...
Source: Roche Media News - Category: Pharmaceuticals Source Type: news

Related Links:

AbstractThe novel coronavirus outbreak induces many concerns about the management of pregnancy, as well as rheumatic and musculoskeletal diseases. The very rapid spread of the infection throughout all inhabited continents leads to a fast-growing number of infected with SARS-CoV-2 and requires answers and special recommendations to the most vulnerable group of people: pregnant woman and patients on immunomodulatory or immunosuppressive treatment. A systematic literature search was performed in Embase, MEDLINE, and Scopus database for studies describing COVID-19 infection in pregnant women diagnosed with rheumatic and muscul...
Source: Rheumatology International - Category: Rheumatology Source Type: research
AbstractRepurposing of antirheumatic drugs has garnered global attention. The aim of this article is to overview available evidence on the use of widely used antirheumatic drugs hydroxychloroquine, methotrexate and colchicine for additional indications. Hydroxychloroquine has endothelial stabilizing and anti-thrombotic effects. Its use has been explored as an adjunctive therapy in refractory thrombosis in antiphospholipid syndrome. It may also prevent recurrent pregnancy losses in the absence of antiphospholipid antibodies. Hydroxychloroquine favourably modulates atherogenic lipid and glycaemic profiles. Methotrexate has b...
Source: Rheumatology International - Category: Rheumatology Source Type: research
Publication date: Available online 25 September 2020Source: Social Science &MedicineAuthor(s): Shaul Kimhi, Hadas Marciano, Yohana Eshel, Bruria Adini
Source: Social Science and Medicine - Category: Psychiatry & Psychology Source Type: research
Gov. Doug Ducey emphasized his commitment to keeping the state open in a “safe and healthy way” during a news conference this week, with no current plans for “dramatic changes” to be made despite “a gradual rise in cases.” “Arizona’s economy is open, Arizona’s educational institutions are open, Arizona’s tourism institutions are open,” the second-t erm Republican said. “The expectation is that they are going to remain open.” The number of deaths reported daily in Arizona…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Publication date: October–December 2020Source: Journal of Optometry, Volume 13, Issue 4Author(s): José M. González-Méijome
Source: Journal of Optometry - Category: Opthalmology Source Type: research
COVID symptoms include a high fever, a new cough, and loss of smell and taste - all of which require the UK public to get a free coronavirus test. But you may also be at risk of COVID-19 if you develop a hidden sign on your tongue. Should you consider self-isolating?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Publication date: Available online 25 September 2020Source: The LancetAuthor(s): Barnaby Flower, Christina Atchison
Source: The Lancet - Category: General Medicine Source Type: research
Publication date: Available online 25 September 2020Source: The LancetAuthor(s): Shuchi Anand, Maria Montez-Rath, Jialin Han, Julie Bozeman, Russell Kerschmann, Paul Beyer, Julie Parsonnet, Glenn M Chertow
Source: The Lancet - Category: General Medicine Source Type: research
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19. It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
The year of the rat is off to an ominous start. “We just stay home and don’t go out,” says Mr. Dong. The 33-year-old researcher, who provided only one name, has no other options. He, his wife and their 3-month-old daughter live in Wuhan, the epicenter of an unfolding global health crisis. They’re treating the forced time at home as a holiday, though he says, “this is different than any of them before.” Families like his huddle in their homes, fearful that if they venture out, they will get sick. Since the first cases of a previously unknown pneumonia-like illness emerged in December, Wuh...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Source Type: news
More News: Common Cold | Coronavirus | Cough | COVID-19 | Emergency Medicine | Epidemiology | Flu Pandemic | Food and Drug Administration (FDA) | Infectious Diseases | Influenza | Laboratory Medicine | MERS | Middle East Health | Pandemics | Pharmaceuticals | Pneumonia | Respiratory Medicine | SARS | Urology & Nephrology | USA Health | WHO